Using AI to identify patients with undiagnosed ATTR-CM
Finding undiagnosed ATTR-CM patients using AI technology in clinical settings
['FUNDING_SBIR_2'] · ATOMO, INC · NIH-10912831
This study is working on a new way to help doctors find out if someone has a heart condition called ATTR-CM more accurately and quickly, using smart technology, so that patients can get the right tests and treatments sooner.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ATOMO, INC (nih funded) |
| Locations | 1 site (WEST LAKE HILLS, UNITED STATES) |
| Trial ID | NIH-10912831 on ClinicalTrials.gov |
What this research studies
This research aims to improve the diagnosis of Transthyretin Amyloidosis with cardiac myopathy (ATTR-CM) by utilizing artificial intelligence technology in clinical settings. Many patients with ATTR-CM remain undiagnosed or are misdiagnosed due to the condition's variable presentation and low prevalence. The study will develop a precision screening system that identifies individuals at risk for ATTR-CM, allowing for timely genetic testing and appropriate treatment. By enhancing diagnostic accuracy, the research seeks to reduce the time to diagnosis and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals experiencing unexplained heart failure symptoms or those with a family history of amyloidosis.
Not a fit: Patients who have already been diagnosed with ATTR-CM or those without any cardiovascular symptoms are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and treatment for patients with ATTR-CM, potentially saving lives and reducing healthcare costs.
How similar studies have performed: Previous research has shown promise in using AI for diagnostic purposes in other medical conditions, indicating potential success for this novel approach.
Where this research is happening
WEST LAKE HILLS, UNITED STATES
- ATOMO, INC — WEST LAKE HILLS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MYERS, KELLY D — ATOMO, INC
- Study coordinator: MYERS, KELLY D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cardiovascular Diseases